

City of Hope is an independent biomedical research and treatment center for cancer, diabetes and other life-threatening diseases.
Founded in 1913, City of Hope is a leader in bone marrow transplantation and immunotherapy such as CAR T cell therapy. City of Hope’s translational research and personalized treatment protocols advance care throughout the world. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a wholly owned subsidiary, was launched in 2019 and is dedicated to serving employers and their health care partners by providing access to City of Hope’s exceptional cancer expertise.
A National Cancer Institute-designated comprehensive cancer center and a founding member of the National Comprehensive Cancer Network, City of Hope is ranked among the nation’s “Best Hospitals” in cancer by U.S. News & World Report and received Magnet Recognition from the American Nurses Credentialing Center. Its main campus is located near Los Angeles, with additional locations throughout Southern California and in Arizona.
Pay Rate: $34.5 - $37.82 per hour
Join the forefront of groundbreaking research at the Beckman Research Institute of City of Hope, where we're changing lives and making a real difference in the fight against cancer, diabetes, and other life-threatening illnesses. Our dedicated and compassionate faculty and staff are driven by a common mission: Contribute to innovative approaches in predicting, preventing, and curing diseases, shaping the future of medicine through cutting-edge research.
A Postdoctoral Fellowship opportunity is immediately available for the highly motivated individual in the research group of Dr. Krupal Patel within the Department of Surgery. Dr. Patel leads an exciting and dynamic research group at the forefront of studies on the immuno-oncology in head and neck cancers. The focus of the translational lab is to generate preclinical data with rational combination of novel therapies that can modulate tumor microenvironment. To accomplish this goal, the lab is focused on generating high fidelity ex vivo and animal models. Their goals are to identify key molecular and immunologic pathways activated by these novel therapies that can be targeted to enhance anti-tumor immunity.
You will directly work on projects focused on head and neck cancers, specifically squamous and melanoma cancers. This work includes developing and performing translational pre-clinical research studies, drafting original research and review articles and publishing in peer reviewed journals, and developing and presenting abstracts at national and international conferences.
You will also lead and conduct experiments focused on immune cell phenotyping and tumor microenvironment profiling with a variety of multi-omic toolsets, with the goal of identifying clinical biomarkers and developing novel therapeutic opportunities. Prior experience with tissue culture, animal models, high-parameter flow cytometry, spatial transcriptomics or proteomics, and cell gene engineering techniques is desired, but not required.
This is an outstanding opportunity for a very motivated and ambitious scientist to work on projects that may directly be translated to clinic.
Your qualifications should include:
City of Hope is an equal opportunity employer.
To learn more about our Comprehensive Benefits, please CLICK HERE.